Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance

Author(s):
Chatzigeorgioua, A.; Seijkens, T.; Zarzycka, B.; Engel, D.; Poggi, M.; Berg, S. van den; Soehnlein, O.; Winkels, H.; Beckers, L.; Lievens, D.; Driessen, A.; Kusters, P.; Biessen, E.; Garcia-Martin, R.; Ameln, A.K.V.; Gijbels, M.; Noelle, R.; Boon, L.; Hackeng, T.; Schulte, K.; Xu, A.M.; Vriend, G.; Nabuurs, S.; Chung, K.J.; Dijk, K.W. van; Rensen, P.C.N. (0000-0002-8455-4988); Gerdes, N.; Winther, M. de; Block, N.L.; Schally, A.V.; Weber, C.; Bornstein, S.R.; Nicolaes, G.; Chavakis, T.; Lutgens, E.
Published
2014
Publication type
Article / Letter to editor
metabolismtype 2 diabetesimmunity
Date issued
2014-02-18
Language
English
Is part of
Proceedings of the National Academy of Sciences (2014), Vol. 111, no. 7, p. 2686-2691
hdl
1887/103143
doi
10.1073/pnas.1400419111